BEGIN:VCALENDAR VERSION:2.0 PRODID:-//swoogo.com//NONSGML kigkonsult.se iCalcreator 2.27.21// CALSCALE:GREGORIAN BEGIN:VEVENT UID:b00423a63ffa6ee0702e320b4e1e7d30a5237697@swoogo.com DTSTAMP:20240328T182543Z DESCRIPTION:2020 has brought COVID to most of the world and disruption acro ss industries. The pharmaceutical industry didn’t escape impact with suppl y chains disconnected\, trials halted\, and drug shortages caused by spike s in demand for drugs thought to provide some hope for COVID relief. While COVID has been a supply-side disruption\, recovery through the summer has been swift. At the same time\, COVID has been a demand side catalyst. Eng agement of capacity for vaccine manufacture…at risk…has been astonishing. In this exclusive session\, Dave Windley\, managing director of Jeffries L LC\, will look at growth trends and impacts of COVID on contract manufactu ring players.\n\nSPONSORED BY:\n [https://rodmanmedia.swoogo.com/cp-webser ies/pfizer-centreone]\n DTSTART:20200924T180000Z DTEND:20200924T190000Z LAST-MODIFIED:20240328T182543Z LOCATION:https://rodmanmedia.swoogo.com/cp-webseries/v/s-320258 SEQUENCE:0 STATUS:CONFIRMED SUMMARY:Contract Manufacturing Opportunity: COVID Catalyst for Supply Chain Conversion TRANSP:OPAQUE X-ALT-DESC;FMTTYPE=text/html:
2020 has brought COVID to most of the world and disruption across industries. The pharmaceutical industry didn’t esca pe impact with supply chains disconnected\, trials halted\, and drug short ages caused by spikes in demand for drugs thought to provide some hope for COVID relief. While COVID has been a supply-side disruption\, recovery th rough the summer has been swift. At the same time\, COVID has been a deman d side catalyst. Engagement of capacity for vaccine manufacture…at risk…ha s been astonishing. In this exclusive session\, Dave Windley\, managing di rector of Jeffries LLC\, will look at growth trends and impacts of COVID o n contract manufacturing players.
\n\n BEGIN:VALARM ACTION:DISPLAY DESCRIPTION:2020 has brought COVID to most of the world and disruption acro ss industries. The pharmaceutical industry didn’t escape impact with suppl y chains disconnected\, trials halted\, and drug shortages caused by spike s in demand for drugs thought to provide some hope for COVID relief. While COVID has been a supply-side disruption\, recovery through the summer has been swift. At the same time\, COVID has been a demand side catalyst. Eng agement of capacity for vaccine manufacture…at risk…has been astonishing. In this exclusive session\, Dave Windley\, managing director of Jeffries L LC\, will look at growth trends and impacts of COVID on contract manufactu ring players.\n\nSPONSORED BY:\n [https://rodmanmedia.swoogo.com/cp-webser ies/pfizer-centreone]\n TRIGGER:-PT30M END:VALARM END:VEVENT END:VCALENDAR